Rezum therapy for patients with large prostates (≥ 80 g): initial clinical experience and postoperative outcomes.
Evan B GardenDevki ShuklaKrishna T RavivarapuSteven A KaplanAvinash K ReddyAlexander C SmallMichael A PalesePublished in: World journal of urology (2021)
In select LP patients, Rezum provided short-term symptomatic relief and improved voiding function comparable to SP patients. Postoperatively, though alpha-blocker usage decreased significantly, use of other medications did not change, and nearly two-thirds of patients still needed alpha-blockade. Further efforts should explore the possibility of expanding Rezum's inclusion criteria.